Michigan Announces Tool to Aid in Opioids Fight
The new Michigan Automated Prescription System (MAPS) is now equipped with Appriss Health's NarxCare, a data analysis solution to improve patient care and also fight the opioid epidemic in the state.
Michigan's Department of Licensing and Regulatory Affairs announced Jan. 11 that the new Michigan Automated Prescription System (MAPS) is now equipped with Appriss Health's NarxCare, a data analysis solution to improve patient care and also fight the opioid epidemic in the state. As of December 2017, health professionals can access NarxCare within the Appriss Health PMP AWARxE platform.
LARA's announcement described NarxCare as "a robust analytics and care management solution that automatically analyzes MAPS data and a patient's health history, and provides an interactive visualization of usage patterns to help identify potential risk factors." MAPS is administered by the department.
"The addition of NarxCare to MAPS strengthens our prevention efforts in addressing the opioid epidemic in Michigan," Lt. Gov. Brian Calley said. "NarxCare gives prescribers and dispensers a more robust way to better identify potential abuse of opioids and substance use disorders." Calley last month signed Senate Bills 166 and 167, which require prescribers to check a patient's prescription history in MAPS before providing controlled substances to the patient. The bills are now Public Acts 248 and 249 of 2017.
"NarxCare has seamlessly integrated into my clinical workflow," said Dr. Peter Graham, a physician at Sparrow Health System and executive medical director of Sparrow's Physicians Health Plan. "The data visualization in NarxCare has provided me with analytical resources that ultimately improve the care and treatment that I provide for my patients."